Advertisement
Screener

Grace Therapeutics, Inc. (GRCE) Intangible Assets And Goodwill

2.8 / 5 stars · 68/120 Roast Me

Grace Therapeutics, Inc. Intangible Assets And Goodwill

Grace Therapeutics, Inc. (GRCE) had Intangible Assets And Goodwill of CAD 7.74 million as of 2019-03-31, per its 20-F filed 2019-06-26.

Discontinued › Notes

ifrs-full:IntangibleAssetsAndGoodwill · last filed 2019-06-26

  • 2019-03-31: Intangible Assets And Goodwill 7.74M CAD.
  • 2018-03-31: Intangible Assets And Goodwill 10.06M CAD.
  • 2017-03-31: Intangible Assets And Goodwill 12.39M CAD.
  • 2017-02-28: Intangible Assets And Goodwill 12.58M CAD.
Period endIntangible Assets And Goodwill
2019-03-317.74M CAD
20-F · filed 2019-06-26
2018-03-3110.06M CAD
20-F · filed 2019-06-26
2017-03-3112.39M CAD
20-F · filed 2018-06-29
2017-02-2812.58M CAD
20-F · filed 2018-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
VERU INC. (VERU)United States$0.043B-3.93
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98